Results 161 to 170 of about 1,442 (223)

Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS-L Protein-Protein Interaction. [PDF]

Chem Biol Drug Des
Calvo-Barreiro L, Secor M, Damjanovic J, Abdel-Rahman SA, Lin YS, Gabr M.   +5 more
europepmc   +1 more source

Inhibitors Targeting SARS-CoV-2 Papain-Like Protease: Screening, Design, Synthesis, and Biological Evaluation. [PDF]

ChemMedChem
Iuga EO, Gone N, de Godoy MO, Verissimo GC, de Jesus Agostinetto G, Urich L, Krüger N, Kronenberger T, Guido RVC, O'Donoghue AJ, Laufer SA, Pillaiyar T.   +11 more
europepmc   +1 more source

On tricyclic graphs with maximum atom-bond sum-connectivity index. [PDF]

Heliyon
Noureen S, Batool R, Albalahi AM, Shang Y, Alraqad T, Ali A.   +5 more
europepmc   +1 more source

Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancer. [PDF]

Front Pharmacol
Chen YS, O'Hagan S, Day PJR.
europepmc   +1 more source

Understanding the origin of stereoselectivity in the photochemical denitrogenation of 2,3-diazabicyclo[2.2.1]heptene and its derivatives with non-adiabatic molecular dynamics. [PDF]

Beilstein J Org Chem
Gomes LA, Lopez SA.
europepmc   +1 more source

Exploring the molecular mechanism of Coptis-cinnamon in combating gastric cancer via the MAPK Pathway based on network pharmacology. [PDF]

Front Oncol
Wang ZZ, Li YH, Yuan L, Jia SM, Yang P, Liu WJ, Nan Y.   +6 more
europepmc   +1 more source

1,3-Disilabicyclo[1.1.0]butane and η²-Silene Nickel Complex Derived from a Bromosilene. [PDF]

Inorg Chem
Honda S, Ishida S, Iwamoto T.
europepmc   +1 more source

Computational-experimental integration identifies potent carbohydrate-hydrolyzing enzyme inhibitors from Nardostachys jatamansi: molecular docking, dynamics and pharmacokinetic predictions. [PDF]

Front Pharmacol
Iqbal MJ, Malik I, Bernal G, Salas-Burgos AM, Salazar LA.   +4 more
europepmc   +1 more source

Molecular docking and pharmacological investigations of folenolide for its analgesic, anti-inflammatory, and antipyretic applications. [PDF]

Front Pharmacol
Ali FL, Khuda F, Khan Khalil AA, Jan A, Khan MA, Nadeem A, Rasheed A, Ali SS, Ullah A.   +8 more
europepmc   +1 more source